PG110 ONCE DAILY MESALAZINE FOR MAINTAINING REMISSION IS COST-SAVING COMPARED TO TWICE DAILY MESALAZINE- AN ECONOMIC EVALUATION BASED ON THE PODIUM RANDOMISED CONTROLLED TRIAL
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66724-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66724-1/fulltext
Title :
PG110 ONCE DAILY MESALAZINE FOR MAINTAINING REMISSION IS COST-SAVING COMPARED TO TWICE DAILY MESALAZINE- AN ECONOMIC EVALUATION BASED ON THE PODIUM RANDOMISED CONTROLLED TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66724-1&doi=10.1016/S1098-3015(10)66724-1
First page :
Section Title :
Open access? :
No
Section Order :
560